- 1. 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone
- [An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush border of the small intestine and inhibits the intestinal absorption of cholesterol and related phytosterols. As a result, ezetimibe causes a decrease in the level of blood cholesterol or an increase in the clearance of cholesterol from the bloodstream. Overall, the following effects observed are a reduction of hepatic cholesterol stores and a reduction of total cholesterol, LDL cholesterol, and other triglycerides in the blood. ( NCI )] (UMLS (NCI) C1142985) EZETIMIBE;
EZETIMIBE PREPARATION =Organic Chemical; Pharmacologic Substance ;
=[CV350] ANTILIPEMIC AGENTS;
Unclassified Ingredients =EZETIMIBE 10 MG;
| - 51. Fluid, IV
- (UMLS (HL7) C1546684) =Intellectual Product =Specimen Source Codes;
|
- 2. 1-fluoro-2,4-dinitrobenzene
- [Irritants and reagents for labeling terminal amino acid groups. ( MSH )] (UMLS (NCI) C0012463) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 52. Fluid, Joint
- (UMLS (HL7) C1546687) =Intellectual Product =Specimen Source Codes;
|
- 3. 1-Fluoroethene
- [A synthetic, colorless gas that is insoluble in water and soluble in organic solvents. It is used primarily in the production of polyvinyl fluoride and other fluoropolymers. Vinyl fluoride is extremely flammable and emits highly toxic hydrogen fluoride gas when burned. Vinyl fluoride metabolites form covalent DNA adducts that attribute to inhibition of DNA replication and to mutagenicity consequences. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0078265) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 53. Fluid, Kidney
- (UMLS (HL7) C1546690) =Intellectual Product =Specimen Source Codes;
|
- 4. 2'-Fluoro-2',3'-Dideoxyadenosine
- [A fluoro-substituted analog of dideoxyadenosine that inhibits reverse transcriptase, thereby inhibiting telomerase activity and subsequent cell proliferation. ( NCI )] (UMLS (NCI) C0220150) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 54. Fluid, Lumbar Sac
- (UMLS (HL7) C1546704) =Intellectual Product =Specimen Source Codes;
|
- 5. 2-Fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene
- (UMLS (NCI) C0767920) =Organic Chemical; Pharmacologic Substance ;
| - 55. Fluid, Other
- (UMLS (HL7) C1546636) =Intellectual Product =Specimen Source Codes;
|
- 6. 2-Fluoro-9-beta-arabinofuranosyladenine
- [nucleoside analog used alone or in combination with other agents to treat various cancers, especially leukemia. ( CSP )] (UMLS (NCI) C0059985) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =[AN300] ANTINEOPLASTICS, ANTIMETABOLITES;
[AN000] ANTINEOPLASTICS;
9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate;
adenine nucleoside;
nucleoside analog;
=2-F-ara-AMP;
| - 56. Fluid, Pericardial
- (UMLS (HL7) C1546730) =Intellectual Product =Specimen Source Codes;
|
- 7. 2-Fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt
- [The sodium salt form of flurbiprofen, a propionic acid derivative and a member of the phenylalkanoic acid group of non-steroidal antiinflammatory drugs (NSAIDs) with analgesic, antiinflammatory and antipyretic effects. Flurbiprofen non-selectively binds to and inhibits cyclooxygenase (COX). This results in a reduction of arachidonic acid conversion into prostaglandins that are involved in the regulation of pain, inflammation and fever. This NSAID also inhibits carbonic anhydrase, thereby reducing the production of hydrogen and bicarbonate ions. Upon ocular administration, flurbiprofen may reduce bicarbonate ion concentrations leading to a decrease in the production of aqueous humor, thereby lowering intraocular pressure. ( NCI )] (UMLS (NCI) C0304658) =Organic Chemical; Pharmacologic Substance ;
=2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid;
[OP900] OPHTHALMICS, OTHER =FLURBIPROFEN SODIUM 0.03 %;
| - 57. Fluid, Renal Cyst
- (UMLS (HL7) C1546766) =Intellectual Product =Specimen Source Codes;
|
- 8. 2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid
- [A derivative of propionic acid, and a phenylalkanoic acid derivative of non-steroidal antiinflammatory drugs (NSAIDs) with analgesic, antiinflammatory and antipyretic effects. Flurbiprofen non-selectively binds to and inhibits cyclooxygenase (COX). This results in a reduction of arachidonic acid conversion into prostaglandins that are involved in the regulation of pain, inflammation and fever. This NSAID also inhibits carbonic anhydrase, thereby reducing the production of hydrogen and bicarbonate ions. Upon ocular administration, flurbiprofen may reduce bicarbonate ion concentrations leading to a decrease in the production of aqueous humor, thereby lowering intraocular pressure. ( NCI )] (UMLS (NCI) C0016377) =Organic Chemical; Pharmacologic Substance ;
=Propionic Acids;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC =2-Fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt;
FLURBIPROFEN 100 MG;
FLURBIPROFEN 50 MG;
| - 58. Fluid, Respiratory
- (UMLS (HL7) C1546640) =Intellectual Product =Specimen Source Codes;
|
- 9. 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1H,3H]-quinazolinedione
- [3-(2-(4-(p-fluorobenzoyl)-piperidino) ethyl)-2,4-quinazolinedione. ( CSP )] (UMLS (NCI) C0022616) =Organic Chemical; Pharmacologic Substance =quinazoline;
serotonin inhibitor | - 59. Fluid, Shunt
- (UMLS (HL7) C1546776) =Intellectual Product =Specimen Source Codes;
|
- 10. 5 fluorodeoxycytidine
- [ ] (UMLS (CSP) C0597703) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance =deoxycytidine;
halocarbon compound;
nucleoside analog;
| - 60. fluidity
- [the physical property of a substance that enables it to flow. ( CSP )] (UMLS (CSP) C0596579) =Quantitative Concept ;
=Physical Phenomenon;
|
- 11. 5 fluorouridine
- [uridine analogs; 18F-labeled compound. ( CSP )] (UMLS (CSP) C0049192) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =deoxyuridine;
fluoropyrimidine;
halocarbon compound;
nucleoside analog | - 61. Fluimucetin
- (UMLS (NCI) C1510761) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 12. 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione
- [An anticancer drug that belongs to the family of drugs called antimetabolites. ( NCI )] (UMLS (NCI) C0016778) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
| - 62. Fluimucil
- (UMLS (NCI) C0699251) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 13. 5-Fluoro-2-Deoxycytidine
- [An antimetabolite consisting of a fluorinated pyrimidine analog with potential antineoplastic activity. As a prodrug, 5-fluoro-2-deoxycytidine is converted intracellularly, by deaminases, to the cytotoxic agent 5-Fluorouracil (5-FU). 5-FU is subsequently metabolized to active metabolites including 5-fluoro-2-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP binds to and inhibits thymidylate synthase, thereby reducing the production of thymidine monophosphate leading to depletion of thymidine triphosphate. This inhibits DNA synthesis and cell division. FUTP competes with uridine triphosphate for incorporation into the RNA strand leading to an inhibition of RNA and protein synthesis. Other fluorouracil metabolites also get incorporated into both DNA and RNA, thereby further hampering cellular growth. ( NCI )] (UMLS (NCI) C0049174) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 63. Fluindione
- (UMLS (NCI) C0117899) =Organic Chemical; Pharmacologic Substance ;
|
- 14. 5-Fluoropyrimidinone
- [A fluoronucleoside that inhibits pyrimidine synthesis, interfering with DNA synthesis. ( NCI )] (UMLS (NCI) C0393034) =Organic Chemical; Pharmacologic Substance ;
| - 64. fluke
- [class of parasitic flukes consisting of three subclasses, Monogenea, Aspidogastrea, and Digenea; the digenetic trematodes are the only ones found in man; organisms are endoparasites and require two hosts to complete their life cycle. ( CSP )] (UMLS (CSP) C0040818) =Invertebrate ;
=flatworm;
=Schistosoma |
- 15. 5-Fluorouracil/epi
- [An injectable collagen matrix gel containing the antimetabolite fluorouracil and the symhathicomimetic agent epinephrine with potential antineoplastic activity. After intratumoral injection, fluorouracil is converted into the active metabolite 5-fluoroxyuridine monophosphate that competes with uracil during RNA synthesis whereas another active metabolite 5-5-fluoro-2'-deoxyuridine-5'-O-monophosphate inhibits thymidylate synthase, thereby interfering with DNA synthesis. Epinephrine, a potent vasoconstrictor, is added to the gel to enhance penetration of fluorouracil into the tumor tissue and reduce dispersion to the surrounding tissues thereby enhancing the local concentration of fluorouracil and increasing its anti-tumor activity. Intratumoral injection of fluorouracil combined with epinephrine may potentially increase chemotherapeutic efficacy compared to systemic administration and reduce systemic toxicity and side effects. ( NCI )] (UMLS (NCI) C0281426) =Clinical Drug
| - 65. Flumedroxone
- (UMLS (NCI) C0060492) =Steroid; Pharmacologic Substance
|
- 16. 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
- (UMLS (NCI) C1176020) Sunitinib =Organic Chemical; Pharmacologic Substance
| - 66. FLUMETHASONE
- [An anti-inflammatory glucocorticoid used in veterinary practice. ( MSH )] (UMLS (NCI) C0016294) =Steroid; Pharmacologic Substance; Hormone
|
- 17. 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid
- [A synthetic quinolinecarboxylic acid analogue with antineoplastic properties. Brequinar inhibits the enzyme dihydroorotate dehydrogenase, thereby blocking de novo pyrimidine biosynthesis. This agent may also enhance the in vivo antitumor effect of antineoplastic agents such as 5-FU. (NCI04) ( NCI )] (UMLS (NCI) C0280509) =Organic Chemical; Pharmacologic Substance
| - 67. Flumethasone Pivalate
- (UMLS (NCI) C0060494) =Steroid; Pharmacologic Substance
|
- 18. 9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
- [A synthetic glucocorticoid receptor agonist with metabolic, anti-inflammatory and immunosuppressive activity. Desoximetasone activates specific intracellular receptors, which bind to distinct sites on DNA to modify gene transcription. This results in an induction of the synthesis of anti-inflammatory proteins and suppression of the synthesis of inflammatory mediators. This leads to an overall reduction in chronic inflammation and autoimmune reactions. Desoximetasone is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. ( NCI )] (UMLS (NCI) C0011707) =Steroid; Pharmacologic Substance; Hormone =(11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione;
Pregnadienediols;
[DE200] ANTI-INFLAMMATORY, TOPICAL;
=DESOXIMETASONE 0.25 %;
DESOXIMETASONE 0.5 %;
DESOXIMETASONE 0.05 % | - 68. FluMist
- (UMLS (NCI) C1311943) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
|
- 19. 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate
- [The acetate salt form of fluorometholone, a synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Fluorometholone acetate exerts its effect by interacting with cytoplasmic glucocorticoid receptors and subsequently activates glucocorticoid receptor mediated gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. ( NCI )] (UMLS (NCI) C0724587) Fluorometholone Acetate;
FLUOROMETHOLONE ACETATE PREPARATION =Steroid; Pharmacologic Substance ;
=FLUOROMETHOLONE;
=FLUOROMETHOLONE ACETATE 0.1 %;
| - 69. flunarizine
- [Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. ( MSH )] (UMLS (CSP) C0016295) =Organic Chemical; Pharmacologic Substance ;
|
- 20. FLU D/T AVIAN FLU VIRUS
- [ ] (UMLS (ICD9CM) C1955789) Influenza due to identified avian influenza virus;
=Disease or Syndrome | - 70. FLUNISOLIDE
- [A synthetic corticosteroid with antiinflammatory and antiallergic properties. Flunisolide is a glucocorticoid receptor agonist that binds to cytoplasmic glucocorticoid receptors and subsequently translocates to the nucleus where it initiates the transcription of glucocorticoid-responsive genes such as lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both are potent mediators of inflammation. ( NCI )] (UMLS (NCI) C0060501) =Steroid; Pharmacologic Substance =(6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione;
[NT200] ANTI-INFLAMMATORIES, NASAL;
[RE101] ANTI-INFLAMMATORIES, INHALATION;
=flunisolide 0.25 MG/ACTUAT;
flunisolide 0.025 MG/ACTUAT |
- 21. Flu Matrix
- [A short chain synthetic antigenic peptide derived from the Influenza virus A matrix protein presented by HLA-A2 multi histocompatibility complex (MHC) class I molecules. The Flu-Matrix antigen stimulates the lytic functions of the alphabeta CD8+ cytotoxic T lymphocytes (CTLs) which are part of the acquired immune system capable of eradicating virus-infected or malignant-tumor cells. ( NCI )] (UMLS (NCI) C0796514) Flu Matrix Antigen;
Flu Matrix Peptide;
Flu Matrix Protein;
FLU-MP;
Influenza Matrix Peptide =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 71. flunitrazepam
- [A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. ( MSH )] (UMLS (CSP) C0016296) =Organic Chemical; Pharmacologic Substance ;
|
- 22. Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide
- (UMLS (NCI) C1327763) Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3 /MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide;
=Therapeutic or Preventive Procedure; ;
| - 72. FLUNIXIN
- (UMLS (NCI) C0060502) =Organic Chemical; Pharmacologic Substance
|
- 23. Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide
- (UMLS (NCI) C1327764) Flu Matrix/gp100 Antigen/Keyhole Limpet Hemocyanin/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide;
=Therapeutic or Preventive Procedure; ;
| - 73. Flunoxaprofen
- (UMLS (NCI) C0060504) =Organic Chemical; Pharmacologic Substance
|
- 24. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/QS21/Tyrosinase Peptide
- (UMLS (NCI) C1327766) Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/QS21/Tyrosinase Peptide =Therapeutic or Preventive Procedure; ;
| - 74. Fluor-Op
- (UMLS (NCI) C0720477) =Steroid; Pharmacologic Substance
|
- 25. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Melan-A/NY-ESO-B/Tyrosinase Peptide
- (UMLS (NCI) C1327765) Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/NY-ESO-B/Tyrosinase Peptide =Therapeutic or Preventive Procedure; ;
| - 75. fluorene
- [A family of diphenylenemethane derivatives. ( MSH )] (UMLS (CSP) C0016311) =Organic Chemical; Hazardous or Poisonous Substance ;
=PAH;
=hexafluorenium;
|
- 26. Flu Matrix/gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide
- (UMLS (NCI) C0796515) =Therapeutic or Preventive Procedure
| - 76. FLUORESCEIN
- [phthalic yellow-green dye used as an indicator and diagnostic aid; used therapeutically as a diagnostic aid in corneal injuries and corneal trauma; also used to label antibodies for fluorescence. ( CSP )] (UMLS (NCI) C0060520) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =benzopyran;
Fluoresceins;
fluorescent dye;
[OP900] OPHTHALMICS, OTHER =Fluorescein Sodium;
|
- 27. flu vaccine
- [orthomyxovirus vaccine; the composition of the vaccine is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains; the vaccine is usually bivalent or trivalent, containing one or two influenza virus A strains and one influenza virus B strain. ( CSP )] (UMLS (CSP) C0021403) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =viral vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
| - 77. Fluorescein angiography
- [visualization of a vascular system after intravenous injection of a fluorescein solution; images may be photographed or televised; used especially in studying the retinal and uveal vasculature. ( CSP )] (UMLS (HL7) C0016313) =Diagnostic Procedure =Angiogram;
Modality |
- 28. FLU W MANIFESTATION NEC
- [ ] (UMLS (ICD9CM) C0155871) =Disease or Syndrome
| - 78. Fluorescein Angioscopy
- (UMLS (HL7) C1548855) =Health Care Activity =Consent Type;
|
- 29. FLU W RESP MANIFEST NEC
- (UMLS (ICD9CM) C0021414) =Disease or Syndrome
| - 79. Fluorescein Sodium
- (UMLS (NCI) C0147866) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =FLUORESCEIN;
=FLUORESCEIN SODIUM 0.6 MG;
FLUORESCEIN SODIUM 1 MG;
FLUORESCEIN SODIUM 10 %;
FLUORESCEIN SODIUM 9 MG;
FLUORESCEIN SODIUM 0.25 %;
FLUORESCEIN SODIUM 2 %;
FLUORESCEIN SODIUM 25 % |
- 30. Fluanisone
- (UMLS (NCI) C0060473) =Organic Chemical; Pharmacologic Substance
| - 80. fluorescence
- [absorption of a photon of light followed, after a delay, by emission of a photon of longer wavelength. ( CSP )] (UMLS (CSP) C0016315) =Natural Phenomenon or Process =light emission;
|
- 31. Fluatox
- (UMLS (NCI) C1510760) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 81. fluorescence anisotropy
- [ ] (UMLS (CSP) C0085813) =Natural Phenomenon or Process ;
|
- 32. Fluazuron
- (UMLS (NCI) C0536903) =Organic Chemical; Pharmacologic Substance
| - 82. Fluorescence Light Microscopy
- [microscope that irradiates fluorescent materials or specimens with ultraviolet, violet, and occasionally blue light, causing the materials to fluoresce. ( CSP )] (UMLS (NCI) C0026022) =Laboratory Procedure ;
=microscopy;
|
- 33. Fluctuations of weight
- (UMLS (NCI) C0241729) =Finding
| - 83. fluorescence polarization
- [measurement of the polarization of fluorescent light from solutions or microscopic specimens; used to provide information concerning molecular size, shape, and conformation, molecular anisotropy, electronic energy transfer, molecular interaction, including dye and coenzyme binding, and the antigen-antibody reaction. ( CSP )] (UMLS (CSP) C0016316) =Laboratory Procedure =optical polarization;
|
- 34. Fludarabine/Melphalan
- (UMLS (NCI) C0796646) =Therapeutic or Preventive Procedure
| - 84. Fluorescence polarization immunoassay (FPIA)
- [Immunoassay, Fluorescence Polarization ( HL7V3.0 )] (UMLS (HL7) C0079365) =Laboratory Procedure ;
=ObservationMethod;
|
- 35. Fludarabine/Thalidomide
- (UMLS (NCI) C0935787) =Therapeutic or Preventive Procedure ;
| - 85. fluorescence recovery after photobleaching
- [method used to study lateral movements of membrane proteins and lipids; a small area of a cell membrane is bleached by laser light and the amount of time necessary for unbleached fluorescent marker tagged proteins to diffuse back into the bleached site is a measurement of the cell membrane's fluidity. ( CSP )] (UMLS (CSP) C1138405) FRAP;
FRAP (fluorescence recovery after photobleaching);
=Laboratory Procedure ;
=fluorimetry;
|
- 36. Fludarabine/UCN-01
- (UMLS (NCI) C0879274) =Therapeutic or Preventive Procedure
| - 86. fluorescence resonance energy transfer
- [method used to evaluate interactions and different conformational states of molecules. ( CSP )] (UMLS (CSP) C0597717) =Laboratory Procedure ;
=fluorescence spectrometry;
|
- 37. Fludiazepam
- (UMLS (NCI) C0060485) =Organic Chemical; Pharmacologic Substance
| - 87. fluorescence spectrometry
- [measurement of the intensity and quality of fluorescence ( CSP )] (UMLS (CSP) C0037802) =Laboratory Procedure ;
=fluorimetry;
=fluorescence resonance energy transfer |
- 38. Flufenazine Decanoate
- [The decanoate salt form of fluphenazine, a phenothiazine with antipsychotic activity. Fluphenazine decanoate exerts its actions by blocking postsynaptic dopamine D2 receptors in the limbic, cortical system and basal ganglia. This prevents the actions of dopamine, thereby reducing the hallucinations and delusions that are associated with schizophrenia. ( NCI )] (UMLS (NCI) C0060580) =Organic Chemical; Pharmacologic Substance =1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
=FLUPHENAZINE DECANOATE 25 MG/ML;
| - 88. fluorescence spectrophotometry
- [ ] (UMLS (CSP) C0242505) =Laboratory Procedure ;
|
- 39. Flufylline
- (UMLS (NCI) C0060489) =Organic Chemical ;
| - 89. fluorescence spectroscopy
- [Fluorescent spectroscopy or fluorometry is a type of electromagnetic spectroscopy used for analyzing fluorescent spectra. It involves using a beam of light, usually ultraviolet light, that excites the electrons in molecules of certain compounds and causes them to emit light of a lower energy, typically, but not necessarily, visible light. ( NCI )] (UMLS (CSP) C0242506) =Laboratory Procedure ;
|
- 40. fluid
- [nonsolid state of matter in which the atoms or molecules are free to move past each other, as in a gas or liquid. ( CSP )] (UMLS (CSP) C1704353) =Substance ;
=physical state;
=machining fluid;
| - 90. fluorescent antibody
- [any immunohistochemical method using antibody labeled with a fluorescent dye and frequently examined by fluorescence microscopy. ( CSP )] (UMLS (CSP) C0016318) =Laboratory Procedure =immunocytochemistry;
|
- 41. Fluid
- (UMLS (HL7) C1546638) =Intellectual Product =Specimen Source Codes;
| - 91. fluorescent dye
- [dyes that emit light when exposed to light; the wave length of the emitted light is usually longer than that of the incident light; fluorochromes are substances that cause fluorescence in other substances, that is, dyes used to mark or label other compounds with fluorescent tags, and they are used as markers in biochemistry and immunology. ( CSP )] (UMLS (CSP) C0016320) =Indicator, Reagent, or Diagnostic Aid =dye;
=ethidium;
FLUORESCEIN;
radiofluorescent probe;
|
- 42. Fluid and Electrolyte Manifestation
- (UMLS (NCI) C1333624) =Finding
| - 92. fluorescent probe
- [ ] (UMLS (CSP) C0016321) =Indicator, Reagent, or Diagnostic Aid
|
- 43. fluid dram
- [1 [foz_us]/8 ( HL7V3.0 )] (UMLS (HL7) C1552936) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens | - 93. Fluoresone
- (UMLS (NCI) C0619286) =Organic Chemical
|
- 44. fluid flow
- [translocation of fluids. ( CSP )] (UMLS (CSP) C0596578) =Natural Phenomenon or Process ;
=Physical Phenomenon;
=water flow;
microfluidics;
| - 94. fluoridation
- [incorporation or addition of fluoride in a compound. ( CSP )] (UMLS (CSP) C0687703) =Natural Phenomenon or Process ;
=halogenation;
|
- 45. FLUID OVERLOAD
- [abnormal increase in the volume of circulating fluid (plasma) in the body. ( CSP )] (UMLS (ICD9CM) C0546817) =Disease or Syndrome ;
=ASCVD;
Metabolic Disease | - 95. fluorimetry
- [the measurement of fluorescence. ( CSP )] (UMLS (CSP) C0016352) =Laboratory Procedure =spectrometry;
=fluorescence spectrometry;
fluorescence recovery after photobleaching |
- 46. Fluid, Abdomen
- (UMLS (HL7) C1546633) =Intellectual Product =Specimen Source Codes;
| - 96. fluoro fatty acid
- [ ] (UMLS (CSP) C0598430) =Lipid ;
|
- 47. Fluid, Acne
- (UMLS (HL7) C1546535) =Intellectual Product =Specimen Source Codes;
| - 97. fluoroaminoacid
- [amino acid containing fluoride. ( CSP )] (UMLS (CSP) C0596580) =Amino Acid, Peptide, or Protein ;
=haloaminoacid;
=2-(Difluoromethyl)-DL-ornithine |
- 48. Fluid, Cyst
- (UMLS (HL7) C1546585) =Intellectual Product =Specimen Source Codes;
| - 98. fluorocarbon polymer
- [dense, inert resin made up of carbon and fluorine, with or without other halogens or hydrogen. ( CSP )] (UMLS (CSP) C0016337) =Organic Chemical =fluorohydrocarbon;
plastic |
- 49. Fluid, Cystostomy Tube
- (UMLS (HL7) C1546584) =Intellectual Product =Specimen Source Codes;
| - 99. fluorocarbon respiratory assist
- [ ] (UMLS (CSP) C0599337) =Therapeutic or Preventive Procedure ;
|
- 50. Fluid, Hydrocele
- (UMLS (HL7) C1546668) =Intellectual Product =Specimen Source Codes;
| - 100. Fluorocarbons
- [Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes. ( MSH )] (UMLS (HL7) C0016340) =Organic Chemical =artificial blood;
fluorohydrocarbon =perfluorodecalin;
Perflubron |
home
